Multiplex Leukemia Cytogenetics & PCR Panel (28 Translocations, 80 Breakpoints: CML, AML, ALL) in UAE | 2,800 AED

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
Premium Logistics: Temperature-controlled cold-chain home collection and VIP mobile phlebotomy available for peripheral blood specimens between 8 AM and 11 PM daily.
Clinical Guidance: Post-test telephonic consultation with our specialist team for result interpretation and clinical decision support.
Insurance: Direct billing verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

This advanced multiplex cytogenetics and PCR panel simultaneously screens 28 key chromosomal translocations and 80 breakpoints associated with chronic myeloid leukemia (CML), acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL). The assay provides a comprehensive genomic blueprint for precise leukemia subtyping, risk stratification, and minimal residual disease monitoring in a single integrated workflow.

Feature	Multiplex PCR + Cytogenetics Panel	Karyotyping / FISH Only
Detection Precision	>99.9% across all 80 breakpoints	~85% – limited to large structural rearrangements
Methodology	Multiplex RT-PCR with LC‑MS/MS cross‑validation	Conventional karyotyping or single‑probe FISH
Turnaround Time	5–7 working days	14–21 working days

Physician Insight & Safety Protocols

Ms. Lina Osama Zaki Quteineh – Consultant Medical Genetics (DHA Registration ID: 9294403) states: “This integrated cytogenetics and molecular panel delivers a high-resolution genomic map essential for modern leukemia management. The breadth of breakpoint coverage enables precise classification and longitudinal monitoring that single-gene tests cannot match. Every result is interpreted within the full clinical context to guide personalized therapeutic decisions.”

Advisory Notice

Do not alter or discontinue any prescribed treatment regimen without explicit consultation with your attending physician. This diagnostic panel is designed to complement, not replace, comprehensive clinical evaluation and ongoing hematology-oncology care.

Exclusion Criteria & Emergency Red Flags

Hospital Extraction Only – Bone Marrow Aspirate: Collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. Contraindications include active skin infection at the puncture site, severe coagulopathy (INR >1.5, platelets <50×10⁶/L), or systemic sepsis.

Peripheral Blood Home Collection: Not performed during acute febrile illness (>38.5°C) or if the patient cannot provide informed consent. A valid physician prescription is required unless the test is for surgery clearance, pregnancy monitoring, or pre-travel screening per UAE regulations.

Emergency Red Flags: Sudden severe bone pain, chest pain, uncontrolled bleeding, or high fever following sample collection requires immediate evaluation at the nearest emergency department.

Patient FAQ & Clinical Guidance

1. What does this test detect and why is it essential for leukemia management?

This multiplex panel identifies 28 chromosomal translocations and 80 breakpoints in a single assay, covering CML, AML, and ALL. It enables precise disease subtyping, prognostic risk stratification, and sensitive tracking of minimal residual disease after therapy — information that directly influences treatment intensity and follow-up schedules.

2. How is the sample collected and can a home visit be arranged?

Peripheral blood for the PCR component can be collected at your home by our ISO-certified VIP mobile phlebotomy team using temperature-controlled cold-chain kits, available daily from 8 AM to 11 PM. Bone marrow aspirate required for cytogenetic analysis is collected only within our licensed hospital facility by a specialist. The combined results are integrated into a single comprehensive report.

3. Will my insurance cover the cost and how is billing managed?

We perform direct insurance eligibility verification via WhatsApp prior to your appointment. Most major UAE health insurers cover medically indicated leukemia genomic profiling when accompanied by a physician request. Contact +971 54 548 8731 to confirm your specific plan benefits before scheduling.

UAE Regulatory & Data Privacy Adherence

Data Protection: All patient data is processed and stored exclusively within UAE sovereign cloud infrastructure in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.

Clinical Safety & Consent: Sample collection and testing procedures adhere to the standards set forth in Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring patient safety and informed consent are maintained at every step.

Accredited Facility: Operated under DHA Facility License Number 1143. All methods are ISO 9001:2015 certified and aligned with current DHA/MOHAP diagnostic standards for hematological malignancies.

Clinical & Logistical Metadata

Test Name	Multiplex Leukemia Cytogenetics & PCR Panel (28 Translocations, 80 Breakpoints)
Price (AED)	2,800 AED
Turnaround Time	5–7 Working Days
Sample Type / Matrix	Peripheral Blood (PCR) & Bone Marrow Aspirate (Cytogenetics); bone marrow collection is hospital extraction only; peripheral blood eligible for VIP mobile phlebotomy cold-chain home collection
Methodology Used	Multiplex RT-PCR with LC‑MS/MS Cross‑Validation; Cytogenetic Analysis
ICD-10-CM Code	C92.0, C91.0, C92.1
LOINC Code	34565-3
DHA Facility License & Laboratory Address	DHA License 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE